Cargando…
HER3 protein expression as a risk factor for post-operative recurrence in patients with early-stage adenocarcinoma and adenosquamous carcinoma of the cervix
Patients with cervical adenocarcinoma (AC) and adenosquamous carcinoma (ASC) have a poorer prognosis than those with squamous cell carcinoma (SCC). Erb-b2 receptor tyrosine kinase 3 (HER3) is a member of the epidermal growth factor receptor family and its expression is associated with unfavorable pr...
Autores principales: | Mizuno, Takaaki, Kojima, Yuki, Yonemori, Kan, Yoshida, Hiroshi, Sugiura, Yukiko, Ohtake, Yohei, Okuma, Hitomi S., Nishikawa, Tadaaki, Tanioka, Maki, Sudo, Kazuki, Shimomura, Akihiko, Noguchi, Emi, Kato, Tomoyasu, Shimoi, Tatsunori, Uno, Masaya, Ishikawa, Mitsuya, Fujiwara, Yasuhiro, Ohe, Yuichiro, Tamura, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412725/ https://www.ncbi.nlm.nih.gov/pubmed/32802162 http://dx.doi.org/10.3892/ol.2020.11899 |
Ejemplares similares
-
Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer
por: Mizuno, Takaaki, et al.
Publicado: (2020) -
High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer
por: Yazaki, Shu, et al.
Publicado: (2022) -
High mesothelin expression is correlated with non-squamous cell histology and poor survival in cervical cancer: a retrospective study
por: Takamizawa, Shigemasa, et al.
Publicado: (2022) -
Survival outcomes in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer administered a therapy following trastuzumab emtansine treatment
por: Watanuki, Rurina, et al.
Publicado: (2020) -
Therapeutic target biomarkers of patient-derived xenograft models of gastric-type cervical adenocarcinoma
por: Kojima, Yuki, et al.
Publicado: (2023)